Effects of subinhibitory concentrations of chemical agents on hydrophobicity and in vitro adherence of Streptococcus mutans and Streptococcus sanguis.
The aim of this investigation was to determine whether sublethal concentrations of chlorhexidine (Cx), hexetidine (Hx), cetylpyridinium chloride (Cc), sodium dodecyl sulfate (SDS), sanguinarine (Sg), sodium fluoride (NaF), and ammonium fluoride (NH4F) could affect hydrophobicity and adhesion of Streptococcus sanguis and Streptococcus mutans to saliva-coated hydroxyapatite (S-HA). Determination of the minimum inhibitory concentrations (MICs) showed that both species were susceptible to all agents tested. Growth in the presence of sub-MIC concentrations of Cx, SDS, Cc, NaF, or NH4F did not change significantly the hydrophobicity of S. sanguis cells when compared to the control which lacked any agent. However, growth in the presence of Hx or Sg resulted in a significant reduction in their hydrophobicity. Sub-MIC levels of SDS or Sg in the growth medium resulted in S. mutans cells with increased affinity for hexadecane compared with the control. The adherence of S. sanguis was changed significantly only by Hx or Sg, resulting in less cells adhering to S-HA. However, S. mutans cells previously incubated with NaF, NH4F, or Sg showed a higher adherence to S-HA than the control. The mechanisms of interference with adherence are at present not completely understood. Thus, antimicrobial agents at sub-MIC concentrations can interfere selectively with hydrophobicity and/or adhesion of oral streptococci.
Cai
S
S
Department of Microbiology, University of São Paulo, Brazil.
Simionato
M R
MR
Mayer
M P
MP
Novo
N F
NF
Zelante
F
F
D000327:Adsorption; D000470:Alkaloids / Q000008:administration & dosage / Q000494:pharmacology; D000473:Alkanes; D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000494:pharmacology*; D001422:Bacterial Adhesion / Q000187:drug effects*; D053119:Benzophenanthridines; D002594:Cetylpyridinium / Q000008:administration & dosage / Q000494:pharmacology; D002710:Chlorhexidine / Q000008:administration & dosage / Q000494:pharmacology; D003773:Dental Plaque / Q000382:microbiology; D017886:Durapatite; D005459:Fluorides / Q000008:administration & dosage / Q000494:pharmacology; D006590:Hexetidine / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007546:Isoquinolines; D000644:Quaternary Ammonium Compounds; D012463:Saliva / Q000502:physiology; D012967:Sodium Dodecyl Sulfate / Q000008:administration & dosage / Q000494:pharmacology; D012969:Sodium Fluoride / Q000008:administration & dosage / Q000494:pharmacology; D013295:Streptococcus mutans / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D013298:Streptococcus sanguis / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D013499:Surface Properties; D014867:Water
D000470:Alkaloids; D000473:Alkanes; D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local; D053119:Benzophenanthridines; D007546:Isoquinolines; D000644:Quaternary Ammonium Compounds; D014867:Water; D012967:Sodium Dodecyl Sulfate; C024822:ammonium fluoride; D006590:Hexetidine; D012969:Sodium Fluoride; D017886:Durapatite; C005705:sanguinarine; D002594:Cetylpyridinium; C007932:n-hexadecane; D005459:Fluorides; D002710:Chlorhexidine